We therefore hypothesized the possible role of BDNF and neurotrophic receptor tyrosine kinase 2 (<i>NTRK2</i>)-related polymorphisms in affecting both hippocampal volumes and treatment resistance in MDD. This evidence concerns the gene NTRK2 and major depressive disorder.